Table 3 Treatment attributes
From: Understanding treatment decision making in juvenile idiopathic arthritis: a qualitative assessment
Sub-themes | Supporting quotations |
|---|---|
Risks and Benefits | “…what percent would get side effects, percent that approved, how rapidly they can expect to see improvement.” Clinician 4 |
“So I usually give them a highlight of the risk and just the major…the ones that have the highest frequency of occurring and I will go through all of the minor side effects. And then talk about the benefits.” Clinician 13 | |
Logistics | “Route of administration is a big deal for patients. So, that certainly is something that really needs to be considered.” Clinician 3 |
“Usually, I will kind of explain that these are the options and… what potential cost might be.” Clinician 14 | |
“So I tell parents …. [the patient] could be on this medicine for a long time.” Clinician 4 | |
Family Preferences | “But it’s their choice, not mine.” Clinician 4 |
“You’re finding out and trying to understand what would work best on them from a treatment standpoint as far as administering the medication, what their insurance may or may not pay for, what their tolerance or intolerance to the potential specific side effects may be.” Clinician 3 |